Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18957723rdf:typepubmed:Citationlld:pubmed
pubmed-article:18957723lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18957723lifeskim:mentionsumls-concept:C0027950lld:lifeskim
pubmed-article:18957723lifeskim:mentionsumls-concept:C0007097lld:lifeskim
pubmed-article:18957723lifeskim:mentionsumls-concept:C1302401lld:lifeskim
pubmed-article:18957723lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:18957723lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:18957723lifeskim:mentionsumls-concept:C2745888lld:lifeskim
pubmed-article:18957723pubmed:issue2lld:pubmed
pubmed-article:18957723pubmed:dateCreated2008-10-29lld:pubmed
pubmed-article:18957723pubmed:abstractTextExpression of Human Neutrophil Peptides (HNP) 1-3 was recently found to be associated with development of colorectal cancer. Raised defensin-expression in tumours is believed to stem from increased infiltration of neutrophils into tumour environment. To further specify the role of alpha-defensins in tumourigenesis and progression, HNP1-3 were analyzed in colorectal adenomas and carcinomas of 87 patients and quantified in relation to cancer stage and grading. Using the ProteinChip arrays, HNP1-3 were found upregulated in both colorectal adenomas and carcinomas. By combining the array with Laser capture microscopy we were able to confirm that HNP1-3 are expressed by tumour cells but not by neutrophils or other tumour invading cells. These findings suggest that alpha-defensins are more likely to contribute to tumour growth than they are to mount an effective host anti-tumour response. However, the amount of HNP-expression was not found to be related to tumour stage, grading, and serological tumour markers.lld:pubmed
pubmed-article:18957723pubmed:languageenglld:pubmed
pubmed-article:18957723pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18957723pubmed:citationSubsetIMlld:pubmed
pubmed-article:18957723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18957723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18957723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18957723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18957723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18957723pubmed:statusMEDLINElld:pubmed
pubmed-article:18957723pubmed:issn0278-0240lld:pubmed
pubmed-article:18957723pubmed:authorpubmed-author:MothesHenning...lld:pubmed
pubmed-article:18957723pubmed:authorpubmed-author:KaufmannRolan...lld:pubmed
pubmed-article:18957723pubmed:authorpubmed-author:SettmacherUtz...lld:pubmed
pubmed-article:18957723pubmed:authorpubmed-author:ErnstGüntherGlld:pubmed
pubmed-article:18957723pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:18957723pubmed:authorpubmed-author:MelleChristia...lld:pubmed
pubmed-article:18957723pubmed:issnTypePrintlld:pubmed
pubmed-article:18957723pubmed:volume25lld:pubmed
pubmed-article:18957723pubmed:ownerNLMlld:pubmed
pubmed-article:18957723pubmed:authorsCompleteYlld:pubmed
pubmed-article:18957723pubmed:pagination123-9lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:meshHeadingpubmed-meshheading:18957723...lld:pubmed
pubmed-article:18957723pubmed:year2008lld:pubmed
pubmed-article:18957723pubmed:articleTitleHuman Neutrophil Peptides 1-3--early markers in development of colorectal adenomas and carcinomas.lld:pubmed
pubmed-article:18957723pubmed:affiliationDepartment of General, Visceral and Vascular Surgery, Universitätsklinikum Jena, Jena, Germany.lld:pubmed
pubmed-article:18957723pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18957723pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18957723pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1667entrezgene:pubmedpubmed-article:18957723lld:entrezgene
entrez-gene:1668entrezgene:pubmedpubmed-article:18957723lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18957723lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18957723lld:entrezgene
lhgdn:association:24186lhgdn:found_inpubmed-article:18957723lld:lhgdn
lhgdn:association:24190lhgdn:found_inpubmed-article:18957723lld:lhgdn
lhgdn:association:24198lhgdn:found_inpubmed-article:18957723lld:lhgdn
lhgdn:association:24205lhgdn:found_inpubmed-article:18957723lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18957723lld:pubmed